BBC Health 02 Sep 2026
Former nurse dies amid dementia drug shortages
Pearl Roche died with dementia weeks after her family struggled to get supplies of her medication.
02 Sep 2026
Read →
These trials are currently recruiting participants in the UK. Always speak to your GP or specialist before contacting a trial team.
The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with…
Gut problems, such as constipation, can have an important impact on quality of life of people who have them, and have been…
This is a Phase 1/1b, multicenter, randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single…
The primary objectives of the study are to estimate the risk of major congenital malformations (MCMs) in infants born to women with…
This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the…
Multiple Sclerosis (MS) is a long-term disease that affects over 150,000 people in the UK. Starting treatment early is important for managing…
Living with Brain & Nerves? Your experience can help others. Share what you've learned.
Thousands of UK patients are managing Brain & Nerves. Connect, share experiences, and support each other.
The latest pipeline drugs, clinical breakthroughs, and regulatory approvals from the FDA, EMA and NICE for Brain & Nerves patients.
📋 Information sourced from clinical trial registries, FDA, EMA and published research
View all research →Detailed condition pages for Brain & Nerves are coming soon.
No podcasts available yet for Brain & Nerves
Sign up for updates below to be notified when we release a free patient podcast for this area.